Treatment of B cell lymphoma with chemotherapy plus rituximab: a survival benefit can be demonstrated in the routine data of a regional cancer registry.
Saved in:
| Title: | Treatment of B cell lymphoma with chemotherapy plus rituximab: a survival benefit can be demonstrated in the routine data of a regional cancer registry. |
|---|---|
| Authors: | Krause SW (AUTHOR), Gerken M (AUTHOR), Andreesen R (AUTHOR), Hofstädter F (AUTHOR), Klinkhammer-Schalke M (AUTHOR) |
| Source: | Annals of Hematology. Apr2012, Vol. 91 Issue 4, p561-570. 10p. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 104442824 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Treatment of B cell lymphoma with chemotherapy plus rituximab: a survival benefit can be demonstrated in the routine data of a regional cancer registry. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Krause+SW%22">Krause SW</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gerken+M%22">Gerken M</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Andreesen+R%22">Andreesen R</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hofstädter+F%22">Hofstädter F</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Klinkhammer-Schalke+M%22">Klinkhammer-Schalke M</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Hematology%22">Annals of Hematology</searchLink>. Apr2012, Vol. 91 Issue 4, p561-570. 10p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=104442824 |
| RecordInfo | BibRecord: BibEntity: Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 561 Titles: – TitleFull: Treatment of B cell lymphoma with chemotherapy plus rituximab: a survival benefit can be demonstrated in the routine data of a regional cancer registry. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Krause SW – PersonEntity: Name: NameFull: Gerken M – PersonEntity: Name: NameFull: Andreesen R – PersonEntity: Name: NameFull: Hofstädter F – PersonEntity: Name: NameFull: Klinkhammer-Schalke M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: Apr2012 Type: published Y: 2012 Identifiers: – Type: issn-print Value: 09395555 Numbering: – Type: volume Value: 91 – Type: issue Value: 4 Titles: – TitleFull: Annals of Hematology Type: main |
| ResultId | 1 |